Komori
Tsubakimoto Kogyo (8052) · RiskReframed

Impact of COVID-19 on business activities and performance

First written in FY2021-Q1. 2 of 14 entries say "Materialised", first in FY2021-Q2. Latest entry: FY2026.

14entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q1 – FY2024-Q1MitigatedFY2024-Q3 – FY20242020: 220202021: 320212022: 420222023: 220232024: 220242025: 020252026: 12026
Same theme, other companies
Risk of COVID-19 impacts on business activities, supply chains, demand and financial performanceA theme 1257 companies write about · 1269 as a headwind · 6 as a tailwind

The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1283 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「In addition to cases in which the group’s business activities become impossible due to a major earthquake or other natural disaster, sudden accident or other event, sales and procurement of planned machinery and equipment may be disrupted if customers or suppliers suffer substantial damage to production facilities or other assets, or if infrastructure problems occur. If the group’s overall activities are disrupted by an outbreak of an infectious disease or other event, this may have a material impact on the group’s operating results.」

    The risk description was consolidated from one focused specifically on COVID-19 into a broader “disaster occurrence” risk covering natural disasters, accidents and infectious diseases.
  2. FY2024MitigatedAnnual report

    「During the fiscal year, net sales recovered sharply as sales activities were ramped up in earnest in the post-COVID period.」

    Sales activities were ramped up in earnest after COVID-19, and the impact of infection-related restrictions on sales activities eased, with net sales at the Central Japan Headquarters reaching 121.3% of the previous fiscal year.
  3. FY2024-Q3MitigatedAnnual report

    「During the nine-month period, net sales recovered as sales activities were ramped up in earnest in the post-COVID period.」

    The Central Japan Headquarters states that it ramped up sales activities in earnest after COVID-19 and that net sales recovered. The impact of infection-related restrictions on sales activities has eased in some areas.
  4. FY2024-Q1Pursuit of business normalization alongside concerns about a renewed spread of infectionAnnual report

    「Under these circumstances, the corporate group is working to return its business activities to pre-COVID levels and pursue its targets while taking the safety and health of everyone involved in its business dealings into consideration.」

    The company has indicated a policy of returning business activities to pre-COVID levels while continuing to prioritize safety and health. It also states that there are signs of a renewed spread of infection in Japan.
  5. FY2023-Q3Recovery in activity and continued impact of the infectionAnnual report

    「Under these circumstances, the corporate group has expanded its business activities while making the safety and health of everyone involved in its business dealings its top priority and working to prevent the spread of COVID-19. During the current period, sales activities gradually returned to pre-COVID levels, and we sought to expand performance while making every effort to address the impact of recent shortages of purchased merchandise, delivery delays and merchandise price increases. The corporate group’s performance for the nine-month period was strong, with net sales of ¥78,634 million, a substantial increase to 118.4% of the previous-year period.」

    Sales activities gradually returned to pre-COVID levels, and sales increased as the company addressed shortages of purchased merchandise, delivery delays and price increases despite the continuing impact of the infection.
  6. FY2023-Q2Continued business expansion under activity restrictionsAnnual report

    「As a result, sales activities are gradually returning to pre-COVID levels, and we continue to expand performance while responding flexibly to recent shortages of purchased merchandise, delivery delays and the impact of price increases for merchandise.」

    Although sales activities are gradually returning to pre-COVID levels, the company continues to expand performance while addressing supply shortages, delivery delays and merchandise price increases caused by the infection.
  7. FY2023-Q1Business recovery under activity restrictionsAnnual report

    「Under these circumstances, the corporate group has been expanding its business activities while making the safety and health of everyone involved in its business dealings its top priority and working to prevent the spread of COVID-19. Although sales activities remain subject to some restrictions, they are gradually returning to pre-COVID levels.」

    The company states that it is expanding business activities while prioritizing safety and health, even as infection-related restrictions on sales activities remain, and that sales activities are gradually returning to pre-COVID levels.
  8. FY2022Full-year recovery under infection-related restrictionsAnnual report

    「The global impact of COVID-19 continued, compounded at the end of the fiscal year by Russia’s invasion of Ukraine. This had a major impact on the societies and economies of various countries, including semiconductor and energy shortages, logistics disruptions and soaring raw-material prices.」

    Despite the continued infection, restrictions on economic activity, and component and logistics constraints, the full fiscal year produced higher sales and higher profits, driven by increased order-taking activity and equipment orders for China.
  9. FY2022-Q3Continued sales recovery under infection-related restrictionsAnnual report

    「The group's operating results for the cumulative third quarter of the current fiscal year benefited from receiving an order for polarizing film production equipment in China and generally more active group-wide order-taking activities. Revenue was ¥66,397 million, a slight increase to 102.1% of the year-earlier period, indicating a recovery trend.」

    Although restrictions on sales activities and uncertainty about the outlook due to new variants remained, net sales recovered to 102.1% of the previous-year period, driven by equipment orders for China and increased order-taking activity.
  10. FY2022-Q2Sales recovery under infection-related restrictionsAnnual report

    「The corporate group’s performance for the six-month period was affected in part by an order for polarizer production equipment in China, and order intake increased substantially from the same period of the previous year. Net sales amounted to ¥44,337 million, a slight increase to 101.4% of the previous-year period, indicating a recovery trend.」

    Although restrictions remained on sales activities and travel within Asian countries, net sales recovered to 101.4% of the previous-year period, driven by orders received in China and other factors.
  11. FY2022-Q1Recovery in domestic activity and continued infection-related restrictionsAnnual report

    「The group's operating results for the cumulative first quarter of the current fiscal year benefited from sales activities gradually becoming more active, mainly in Japan, despite continued restrictions to prevent the spread of infection. Revenue increased to ¥21,036 million, or 109.4% of the year-earlier period.」

    Although infection-related restrictions on sales activities continued, activity gradually picked up, mainly in Japan, and net sales recovered to 109.4% of the previous-year period.
  12. FY2021-Q3MaterialisedAnnual report

    「To prevent the spread of infection, we had no choice but to continue restricting and voluntarily suspending direct visits to customers by the sales divisions. Although we conducted sales activities using alternative measures such as teleworking, corporate investment sentiment did not recover. In addition, delivery of the large-volume LCD-related manufacturing equipment recorded in the same period of the previous year was largely completed, leaving only a small amount in the current period. As a result, net sales fell sharply to ¥65,004 million, or 81.6% of the previous-year period. In terms of earnings, despite implementing thorough expense reductions, we were unable to offset the decline in gross profit, resulting in operating income of ¥2,326 million, or 53.2% of the previous-year period, ordinary income of ¥2,798 million, or 59.6%, and net income attributable to owners of the parent of ¥1,885 million, or 60.1%, all representing substantial declines.」

    During the nine-month period, declines in net sales, operating income, ordinary income and net income actually occurred as restrictions on and voluntary suspension of sales visits due to the spread of the infection continued and business investment sentiment failed to recover.
  13. FY2021-Q2MaterialisedAnnual report

    「Regarding the operating results of the Group for the cumulative second quarter consolidated period, direct visits to companies by the sales division had to be restricted and voluntarily curtailed to prevent the spread of infection. Although sales activities were conducted using alternative measures such as teleworking, companies' appetite for capital investment had not recovered. In addition, delivery of the large liquid-crystal display-related manufacturing equipment recorded in the year-earlier period was largely completed. As a result, net sales fell substantially to ¥43,716 million, or 76.4% of the year-earlier period. In terms of earnings, despite thorough cost reductions, the decline in gross profit could not be fully offset, and operating income fell substantially to ¥1,567 million (50.9% of the year-earlier period), ordinary income to ¥1,855 million (56.5%), and profit attributable to owners of the parent to ¥1,255 million (57.9%).」

    During the six-month period, declines in net sales, operating income, ordinary income and net income actually occurred as restrictions on and voluntary suspension of sales visits due to the spread of the infection continued and business investment sentiment failed to recover.
  14. FY2021-Q1First statedAnnual report

    「In addition to restricting and refraining from direct customer visits by the sales division to prevent the spread of infection, revenue from large liquid-crystal display manufacturing equipment recorded in the year-earlier period amounted to only a small amount in the current period. As a result, revenue fell sharply to ¥19,230 million, or 73.2% of the year-earlier period.」

    COVID-19 was disclosed as a new “disaster occurrence,” with the company stating that restrictions on and voluntary suspension of business activities, activity restrictions in various countries, and declines in sales and profits had actually occurred.
Moved together

"Dependence on Capital Investment Trends and Economic Fluctuations" moved the same way as this thread, in the same document, in 3 of its 14 moves.

333222★123456
  1. ★This thread
  2. 1Dependence on Capital Investment Trends and Economic Fluctuations3×
  3. 2Risk of Market Price Declines and Valuation Losses on Held Securities3×
  4. 3Foreign Exchange Risk in Foreign-Currency Transactions and Overseas Subsidiaries3×
  5. 4Strengthening the Domestic Sales Base Through Area Strategies2×
  6. 5Product Development Anticipating Demand for Labor Saving and Workforce Reduction2×
  7. 6Global Economic Uncertainty Stemming from Brexit, China's Slowdown and Other Factors2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Tsubakimoto Kogyo's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Impact of COVID-19 on business activities and performance | TSUBAKIMOTO KOGYO CO.,LTD. (8052) | Komori